Concepedia

Author

Sabrina Giantulli

Sapienza University of Rome

Also Known As

S. Giantulli, Sabrina Giantulli

18

Publications

316

Citations

11

H-Index

24

Concepts

All Affiliations

Sapienza University of RomeUniversity of Rome Tor VergataUniversity of Chieti-PescaraIstituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro
SG

About

Sabrina Giantulli is an author at Sapienza University of Rome specializing in pharmacology, medicine, and nanomedicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

79

2

Engineering

1

1

40

3

Biomedical Engineering

1

1

40

4

Biomolecular Engineering

1

1

42

5

Cell Biology

1

1

24

Sabrina Giantulli

×

11

Publications

213

Citations

11

H-Index

YearCitations

Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma

Celeste De Monte, Simone Carradori, Daniela Secci,

European Journal of Medicinal Chemistry

2015

42

Folate-based single cell screening using surface enhanced Raman microimaging

Claudia Fasolato, Sabrina Giantulli, Ida Silvestri,

Nanoscale

2016

40

RETRACTED ARTICLE: The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells

Francesca De Iuliis, Ludovica Taglieri, Gerardo Salerno,

Investigational New Drugs

2016

24

Effect of 1-MHz ultrasound on the proinflammatory interleukin-6 secretion in human keratinocytes

Sabrina Giantulli, Elisabetta Tortorella, Francesco Brasili,

Scientific Reports

2021

17

Differential effects on membrane permeability and viability of human keratinocyte cells undergoing very low intensity megasonic fields

Fabio Domenici, Francesco Brasili, Sabrina Giantulli,

Scientific Reports

2017

14

Antifolate SERS-active nanovectors: quantitative drug nanostructuring and selective cell targeting for effective theranostics

Claudia Fasolato, Sabrina Giantulli, Angela Capocefalo,

Nanoscale

2019

14

Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer

Alessandro Sciarra, Martina Maggi, Stefano Salciccia,

Oncology

2021

14

Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells

Ludovica Taglieri, Francesca De Iuliis, A. M. Giuffrida,

Oncology Letters

2017

13

PLGA based particles as “drug reservoir” for antitumor drug delivery: characterization and cytotoxicity studies

Laura Chronopoulou, Fabio Domenici, Sabrina Giantulli,

Colloids and Surfaces B Biointerfaces

2019

13

Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation

Francesca De Iuliis, Gerardo Salerno, A. M. Giuffrida,

Tumor Biology

2015

11

Page 1